Filing Details

Accession Number:
0001055726-21-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-09 19:03:30
Reporting Period:
2021-03-05
Accepted Time:
2021-03-09 19:03:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1055726 Inovio Pharmaceuticals Inc. INO Surgical & Medical Instruments & Apparatus (3841) 330969592
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1669080 B. David Weiner 660 W. Germantown Pike
Suite 110
Plymouth Meeting PA 19462
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-05 11,666 $0.00 838,885 No 4 M Direct
Common Stock Disposition 2021-03-08 3,500 $9.18 835,385 No 4 S Direct
Common Stock Acquisiton 2021-03-08 11,667 $0.00 847,052 No 4 M Direct
Common Stock Disposition 2021-03-09 3,500 $9.60 843,552 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-03-05 11,666 $0.00 11,666 $0.00
Common Stock Restricted Stock Unit Disposition 2021-03-08 11,667 $0.00 11,667 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
11,666 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares vested on March 5, 2021. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of restricted stock units granted by the issuer.
  3. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares will vest on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.